Last updated: March 28, 2024
Sponsor: Children's Hospital Colorado
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism
Rett Syndrome
Treatment
Male Rett
Clinical Study ID
NCT06346106
23-0075
Ages < 100 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- English-speaking parents (over the age of 18) of male children (all ages, alive ordeceased) with confirmed genetic diagnosis of male RTT
Exclusion
Exclusion Criteria:
- parents of male MECP2 duplication syndrome
Study Design
Total Participants: 80
Treatment Group(s): 1
Primary Treatment: Male Rett
Phase:
Study Start date:
May 24, 2023
Estimated Completion Date:
April 30, 2024
Connect with a study center
University of Colorado Anschutz Medical Campus
Aurora, Colorado 80045
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.